Given DCLK1’s role in inflammatory liver diseases, tumorigenesis, and metastasis [27,28], we investigated stage-specific miRNA expression in patients with high (40–60 ng/mL) and low (2–20 ng/mL) DCLK1 levels. The gene discussed is DCLK1; the disease is liver disorder.